Pharmaceutisch Weekblad

, Volume 6, Issue 6, pp 245–248 | Cite as

Complex stability of ferrous ascorbate in aqueous solution and its significance for iron absorption

  • C. M. Plug
  • D. Dekker
  • A. Bult
Short Communications

Abstract

The greater absorption of ironin vivo from ferrous ascorbate [Fe(HL)2] as compared with ferrous sulfate has been ascribed both to retardation or prevention of Fe(II) oxidation by ascorbate and to the existence of Fe(II) as a chelate with ascorbate. The available literature and our own results demonstrate that Fe(HL)2 dissociates in aqueous solution into a monomeric cationic species Fe(HL)1+, Fe2+ and HL. The HL anion acts as a monodentate. The low stability constant KFc(HL)., about 20 l.mol-s-1 at Μ = 0 and 25‡C, results in the conclusion that Fe(HL)2 is almost completely dissociated into Fe2+ and HL/s- at about pH = 5, so (chelate) complex formation does not contribute significantly to the increased iron absorption. Between pH = 6 and pH = 8 a solubility enhancing effect of ascorbate is observed which may be of relevance for the iron absorption from ferrous ascorbate.

Keywords

Public Health Iron Sulfate Aqueous Solution Internal Medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Marx JJM, Stiekema J. Mucosal uptake, mucosal transfer and retention of a therapeutic dose of iron. Eur J Clin Pharmacol 1982;23:335–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Goodman Gilman A, Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics. 6th ed. New York: MacMillan Co., 1980:1314–22.Google Scholar
  3. 3.
    Cox TM, O'Donnell MW. Studies on the binding of iron by rabbit intestinal microvillus membranes. Biochem J 1981;194:753–9.PubMedGoogle Scholar
  4. 4.
    Hungerford DM, Linder MC. Interactions of pH and ascorbate in intestinal iron absorption. J Nutr 1983;113:2615–22.PubMedGoogle Scholar
  5. 5.
    Hearn RA, Bugg CE. Calcium binding to carbohydrates: crystal structure of calcium ascorbate dihydrate. Acta Cryst 1974;B30:2705–11.Google Scholar
  6. 6.
    Ulmgren P, Wahlberg O. Equilibrium studies of lascorbate ions. ix. Equilibria between iron(11) ions, ascorbate ions, and protons in 3M NaClO4 medium. Acta Chem Scand 1974;A28:631–7.Google Scholar
  7. 7.
    Al-Meshal IA, Hassan MMA. Ascorbic Acid. In: Florey K, red. Analytical Profiles of Drug Substances, Vol 11. Washington: The American Pharmaceutical Association, 1982:45–78.Google Scholar
  8. 8.
    Kriss EE. Structure of ascorbato-complexes of metals. Russ J Inorg Chem 1978;23:1004–7.Google Scholar
  9. 9.
    Kurbatova GT, Kriss EE, Alekseev Yu E, Sudareva TP. Comparison of the complex-forming properties of ascorbic and 5,6-00′-isopropylidene ascorbic acids in aqueous and aqueous-organic solutions. Russ J Inorg Chem 1980;25:1503–5.Google Scholar
  10. 10.
    Dubey KP, Parveen S. Ascorbate-M(11) systems — Equilibrium studies. Curr Sci 1978;47:415–6.Google Scholar
  11. 11.
    Holzbecher Z, Divis L, Kral M, Sucha L, Vlacil F. Handbook of Organic Reagents in Inorganic Analysis. Chichester: Ellis Horwood Ltd., 1976:76–8.Google Scholar
  12. 12.
    Kurbatova GT, Kriss EE, Alekseev Yu E, Tyumenev VA. Preparation and study of vanadium(iv) and iron(II) ascorbates. Russ J Inorg Chem 1979;24:1047–50.Google Scholar
  13. 13.
    Laurence GS, Ellis KJ. The detection of a complex intermediate in the oxidation of ascorbic acid by ferric ion. J Chem Soc [Dalton] 1972; 1667–70.Google Scholar
  14. 14.
    Martinez P, Uribe D. Study of the complexes of the ascorbic acid-iron(III) system. Z Naturforsch 1982;37b:1446–9.Google Scholar
  15. 15.
    Bult A. Ion-pair and Metal Complex Formation in Drug Analysis. In: Breimer DD, Speiser P, red. Topics in Pharmaceutical Sciences 1983. Amsterdam: Elsevier Science Publishers BV, 1983:3–14.Google Scholar
  16. 16.
    Conrad ME, Schade SG. Ascorbic acid chelates in iron absorption: a role for hydrochloric acid. Gastroenterology 1968;55:35–45.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1984

Authors and Affiliations

  • C. M. Plug
    • 1
  • D. Dekker
    • 2
  • A. Bult
    • 3
  1. 1.Department of Pharmaceutical Analysis and Analytical Chemistry, Subfaculty of PharmacyState University of LeidenRA LeidenThe Netherlands
  2. 2.Servier Nederland BVNN ZoetermeerThe Netherlands
  3. 3.Department of Chemical Pharmacy, Subfaculty of PharmacyState University of UtrechtGH UtrechtThe Netherlands

Personalised recommendations